aluminum hydroxide / magnesium carbonate Oral Suspension [Gaviscon]

RxNorm concept 366007, branded dose form (sbdf).

RxCUI: 366007
Term type: Branded dose form (SBDF)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/366007 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Related concepts

Oral Suspension (DF, has dose form)
Gaviscon (BN, has ingredient)
aluminum hydroxide / magnesium carbonate Oral Suspension (SCDF, tradename of)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 366007 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/366007 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 366007. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.